183 related articles for article (PubMed ID: 24351862)
1. p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma.
Matsuda Y; Wakai T; Hirose Y; Osawa M; Fujimaki S; Kubota M
Int J Mol Sci; 2013 Nov; 14(12):23499-515. PubMed ID: 24351862
[TBL] [Abstract][Full Text] [Related]
2. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.
He S; Lu M; Xue W; Wang Y; Zhao Y; Gao S; Ke Q; Liu Y; Li P; Cui X; Cheng C; Shen A
Med Oncol; 2011 Mar; 28(1):94-104. PubMed ID: 20108172
[TBL] [Abstract][Full Text] [Related]
4. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.
Wang Y; Yu YN; Song S; Li TJ; Xiang JY; Zhang H; Lu MD; Ji F; Hu LQ
J Cancer Res Clin Oncol; 2014 Jun; 140(6):969-78. PubMed ID: 24671224
[TBL] [Abstract][Full Text] [Related]
5. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
6. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
8. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
[TBL] [Abstract][Full Text] [Related]
9. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
10. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
12. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological and prognostic significance of P27
Luo Y; Fu Z; Wu P; Zheng D; Zhang X
Gene; 2020 Apr; 734():144351. PubMed ID: 31982553
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma.
Chen L; Yuan D; Wang GL; Wang Y; Wu YY; Zhu J
J Korean Med Sci; 2010 Oct; 25(10):1438-42. PubMed ID: 20890423
[TBL] [Abstract][Full Text] [Related]
16. 17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma.
Chen J; Zhuo JY; Yang F; Liu ZK; Zhou L; Xie HY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):220-226. PubMed ID: 29748147
[TBL] [Abstract][Full Text] [Related]
17. Expression of Pirh2, a p27(Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27(Kip1) and cell proliferation.
Huang X; Qian X; Cheng C; He S; Sun L; Ke Q; Zhang L; Pan X; He F; Wang Q; Meng J; Ni R; Shen A
Hum Pathol; 2011 Apr; 42(4):507-15. PubMed ID: 21236467
[TBL] [Abstract][Full Text] [Related]
18. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.
Matsuda Y; Ichida T
Med Mol Morphol; 2006 Dec; 39(4):169-75. PubMed ID: 17187177
[TBL] [Abstract][Full Text] [Related]
19. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
[TBL] [Abstract][Full Text] [Related]
20. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Aigelsreiter A; Ress AL; Bettermann K; Schauer S; Koller K; Eisner F; Kiesslich T; Stojakovic T; Samonigg H; Kornprat P; Lackner C; Haybaeck J; Pichler M
Br J Cancer; 2013 May; 108(9):1830-7. PubMed ID: 23591196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
